Rapport Therapeutics, Inc.RR

Rapport Therapeutics, Inc.

10.51USDR
+0.49+4.89%
At close at Mar 14, 23:18 GMT
USD
No trades
See on Supercharts
Back

EBITDA of Rapport Therapeutics, Inc.

Annual data
2023
TTM
‪‪−40.00 M‬‬
‪‪−30.00 M‬‬
‪‪−20.00 M‬‬
‪‪−10.00 M‬‬
‪0.00‬
Period
Value
Change
Change %
TTM
2023
‪‪−36.07 M‬‬
‪‪−25.71 M‬‬
‪−248.41‬%
Quarterly data
Q2 '23
Q1 '24
Q2 '24
Q3 '24
‪‪−24.00 M‬‬
‪‪−18.00 M‬‬
‪‪−12.00 M‬‬
‪‪−6.00 M‬‬
‪0.00‬
Period
Value
Change
Change %
Q3 '24
‪‪−21.42 M‬‬
‪‪−829.00 K‬‬
‪−4.03‬%
Q2 '24
‪‪−20.59 M‬‬
‪‪−3.65 M‬‬
‪−21.54‬%
Q1 '24
‪‪−16.94 M‬‬
‪‪−10.33 M‬‬
‪−156.35‬%
Q2 '23
‪‪−6.61 M‬‬
‪‪−1.43 M‬‬
‪−27.69‬%